209 related articles for article (PubMed ID: 15917666)
1. Molecular beacon imaging of tumor marker gene expression in pancreatic cancer cells.
Yang L; Cao Z; Lin Y; Wood WC; Staley CA
Cancer Biol Ther; 2005 May; 4(5):561-70. PubMed ID: 15917666
[TBL] [Abstract][Full Text] [Related]
2. Real-time detection of gene expression in cancer cells using molecular beacon imaging: new strategies for cancer research.
Peng XH; Cao ZH; Xia JT; Carlson GW; Lewis MM; Wood WC; Yang L
Cancer Res; 2005 Mar; 65(5):1909-17. PubMed ID: 15753390
[TBL] [Abstract][Full Text] [Related]
3. Detection of survivin expression in cervical cancer cells using molecular beacon imaging: new strategy for the diagnosis of cervical cancer.
Xue Y; An R; Zhang D; Zhao J; Wang X; Yang L; He D
Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):204-8. PubMed ID: 21752529
[TBL] [Abstract][Full Text] [Related]
4. Dual FRET molecular beacons for mRNA detection in living cells.
Santangelo PJ; Nix B; Tsourkas A; Bao G
Nucleic Acids Res; 2004 Apr; 32(6):e57. PubMed ID: 15084672
[TBL] [Abstract][Full Text] [Related]
5. Primary application study in early diagnosis of bladder cancer by survivin molecular beacons.
Zhao J; He D; He H; Li L; Zhang LL; Wang XY
Urology; 2007 Jul; 70(1):60-4. PubMed ID: 17656209
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of PAR-4, a pro-apoptotic gene, in pancreatic tumors harboring K-ras mutation.
Ahmed MM; Sheldon D; Fruitwala MA; Venkatasubbarao K; Lee EY; Gupta S; Wood C; Mohiuddin M; Strodel WE
Int J Cancer; 2008 Jan; 122(1):63-70. PubMed ID: 17893871
[TBL] [Abstract][Full Text] [Related]
7. A molecular beacon-based method for screening cervical cancer.
Han S; Li L; Jia X; Ou W; Ma J; Wang H; Zhao J; Zhu Q
J Nanosci Nanotechnol; 2012 Nov; 12(11):8282-6. PubMed ID: 23421207
[TBL] [Abstract][Full Text] [Related]
8. Expression profiles of pancreatic cancer cell lines infected with antisense K-ras-expressing adenoviral vector.
Ohnami S; Aoki K; Yoshida K; Ohnami S; Hatanaka K; Suzuki K; Sasaki H; Yoshida T
Biochem Biophys Res Commun; 2003 Oct; 309(4):798-803. PubMed ID: 13679043
[TBL] [Abstract][Full Text] [Related]
9. Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer.
Gazzaniga P; Gradilone A; Giuliani L; Gandini O; Silvestri I; Nofroni I; Saccani G; Frati L; Aglianò AM
Ann Oncol; 2003 Jan; 14(1):85-90. PubMed ID: 12488298
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of survivin expression by small interfering RNA induces pancreatic cancer cell apoptosis and enhances its radiosensitivity.
Guan HT; Xue XH; Dai ZJ; Wang XJ; Li A; Qin ZY
World J Gastroenterol; 2006 May; 12(18):2901-7. PubMed ID: 16718816
[TBL] [Abstract][Full Text] [Related]
11. [Expression of survivin gene in pancreatic carcinoma].
Liang ZY; Liu TH; Luo YF; Guan J; Wei SZ; Cao JL; Gao J; Cui QC
Zhonghua Bing Li Xue Za Zhi; 2005 Feb; 34(2):67-70. PubMed ID: 15842798
[TBL] [Abstract][Full Text] [Related]
12. [The experiment study on RNAi inhibiting the expression of survivin and inducing the apoptosis of pancreatic cancer cells].
He MX; Meng LX; Tang Y; Li JS; Tian BL; Hu WM; Huang X; Liu ZR; Zhang ZD
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 37(4):520-4. PubMed ID: 16909592
[TBL] [Abstract][Full Text] [Related]
13. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.
Wilentz RE; Chung CH; Sturm PD; Musler A; Sohn TA; Offerhaus GJ; Yeo CJ; Hruban RH; Slebos RJ
Cancer; 1998 Jan; 82(1):96-103. PubMed ID: 9428484
[TBL] [Abstract][Full Text] [Related]
14. [Effect of survivin targeting on cell proliferation and apoptosis in pancreatic cancer cells].
Dai DJ; Lu CD; Lai RY; Guo JM; Meng H
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1894-8. PubMed ID: 15631802
[TBL] [Abstract][Full Text] [Related]
15. Ribozyme against mutant K-ras mRNA suppresses tumor growth of pancreatic cancer.
Kijima H; Yamazaki H; Nakamura M; Scanlon KJ; Osamura RY; Ueyama Y
Int J Oncol; 2004 Mar; 24(3):559-64. PubMed ID: 14767540
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of survivin by siRNA diminishes radioresistance of pancreatic cancer cells.
Kami K; Doi R; Koizumi M; Toyoda E; Mori T; Ito D; Kawaguchi Y; Fujimoto K; Wada M; Miyatake S; Imamura M
Surgery; 2005 Aug; 138(2):299-305. PubMed ID: 16153440
[TBL] [Abstract][Full Text] [Related]
17. DNAzyme-mediated cleavage of survivin mRNA and inhibition of the growth of PANC-1 cells.
Liang Z; Wei S; Guan J; Luo Y; Gao J; Zhu H; Wu S; Liu T
J Gastroenterol Hepatol; 2005 Oct; 20(10):1595-602. PubMed ID: 16174080
[TBL] [Abstract][Full Text] [Related]
18. Lack of prognostic significance of survivin, survivin-deltaEx3, survivin-2B, galectin-3, bag-1, bax-alpha and MRP-1 mRNAs in breast cancer.
O'Driscoll L; Linehan R; M Kennedy S; Cronin D; Purcell R; Glynn S; W McDermott E; D Hill A; J O'Higgins N; Parkinson M; Clynes M
Cancer Lett; 2003 Nov; 201(2):225-36. PubMed ID: 14607338
[TBL] [Abstract][Full Text] [Related]
19. Differential c-erbB-1 and c-erbB-2 mRNA expression in cancer of the pancreas compared with cancer of the papilla of Vater.
Prenzel KL; Warnecke-Eberz U; Brabender J; Baldus SE; Bollschweiler E; Gutschow CA; Drebber U; Hoelscher AH; Schneider PM
World J Gastroenterol; 2006 Jan; 12(3):437-42. PubMed ID: 16489645
[TBL] [Abstract][Full Text] [Related]
20. Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the Wnt/β-catenin signaling pathway.
Xu W; Wang Z; Zhang W; Qian K; Li H; Kong D; Li Y; Tang Y
Cancer Lett; 2015 Jan; 356(2 Pt B):613-27. PubMed ID: 25305448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
